Sfoglia per Autore
Letter to the Editor: reply to Martinelli et al.
2003-01-01 GUERRASIO A; PILATRINO C; D. CILLONI; GOTTARDI E; SAGLIO G
Sodium valproate enhances Imatinib induced apoptosis and growth arrest in Bcr-Abl cell lines
2003-01-01 Morotti A.; Cilloni D.; Messa F.; Pautasso M.; Rege-Cambrin G.; Pilatrino C.; Guerrasio A.; Gottardi E.; Alberti D; Saglio G
Resveratrol and Valproate induce differentiation of AML blasts through NF-kB inhibition
2003-01-01 Morotti A; Pautasso M; Cilloni D; Messa F; Baraban D; Gottardi E; Saglio G
Usefulness of quantitative assessment of Wilms tumor suppressor gene expression in chronic myeloid leukemia patients undergoing imatinib therapy.
2003-01-01 D. CILLONI; SAGLIO G.
MODULATION OF APOPTOSIS
2004-01-01 Saglio G; Morotti A; Cilloni D
Conventional and novel tools for defining the risk of the individual patient with chronic myeloid leukemia and for monitoring treatment
2004-01-01 G. SAGLIO; D. CILLONI
Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia
2004-01-01 SAGLIO G; MOROTTI A; MATTIOLI G; MESSA E; GIUGLIANO E; VOLPE G; REGE-CAMBRIN; G; CILLONI D.
The IKK inhibitor PS1145 allows to overcome Imatinib resistance
2004-01-01 Cilloni D; Messa F; Arruga F; Defilippi I; Morotti A; Messa E; Carturan S; Fava M; Gottardi E; Martinelli G; Baccarani M; Saglio G
SODIUM VALPROATE ENHANCES IMATINIB INDUCED APOPTOSIS AND GROWTH ARREST IN BCR-ABL CELL LINES
2004-01-01 Morotti A; Cilloni D; Pautasso M; Baraban D; Messa F; Arruga F; De Filippi I; Messa E; Carturan S; Rege-cambrin G; Pilatrino C; Guerrasio A; Gottardi E; Saglio G
Over-Expression of the P65 Subunit of NF-kB and Increased DNA Binding Activity of NF-kB Is a Common Event Both in Philadelphia Positive and Negative Chronic Myeloproliferative Disorders.
2004-01-01 Alessandro Morotti; Veronica Ullmannova; Daniela Cilloni; Francesca Messa; Manuela Messa; Ilaria Defilippi; Francesca Arruga; Sonia Carturan; Cedrik Haskovec; Enrico Gottardi; Giuseppe Saglio
Over-expression of the p65 subunit of NF-kB and increased NF-kB binding activity is a common event both in Philadelphia positive and negative Chronic Myeloproliferative Disorders
2004-01-01 Morotti A; Ullmannova V; Cilloni D; Messa F; Messa E; Defilippi I; Arruga F; Carturan S; Haskovec C; Gottardi E; Saglio G
Glivec and CML: a lucky date
2004-01-01 SAGLIO G; CILLONI D; RANCATI F; BOANO L.
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia
2004-01-01 ROSTI G; MARTINELLI G; BASSI S; AMABILE M; TRABACCHI E; GIANNINI B; CILLONI D; IZZO B; DE VIVO A; TESTONI N; CAMBRIN GR; BONIFAZI F; SOVERINI S; LUATTI S; GOTTARDI E; ALBERTI D; PANE F; SALVATORE F; SAGLIO G; BACCARANI M.
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation
2004-01-01 CILLONI D; MESSA F; GOTTARDI E; FAVA M; ARRUGA F; DEFILIPPI I; CARTURAN S; MESSA E; MOROTTI A; GIUGLIANO E; REGE-CAMBRIN G; ALBERTI D; BACCARANI M; SAGLIO G
Abl: the prototype of oncogenic fusion proteins
2004-01-01 G. SAGLIO; D. CILLONI
Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients
2004-01-01 CILLONI D; CARTURAN S; GOTTARDI E; MESSA F; FAVA M; DEFILIPPI I; ARRUGA F; SAGLIO G.
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia
2004-01-01 BACCARANI M; MARTINELLI G; ROSTI G; TRABACCHI E; TESTONI N; BASSI S; AMABILE M; SOVERINI S; CASTAGNETTI F; CILLONI D; IZZO B; DE VIVO A; MESSA E; BONIFAZI F; POERIO A; LUATTI S; GIUGLIANO E; ALBERTI D; FINCATO G; RUSSO D; PANE; F; SAGLIO G; GIMEMA WORKING PARTY ON CHRONIC MYELOID LEUKEMIA.
WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome
2004-01-01 CILLONI D; SAGLIO G
Myelodysplastic syndromes
2004-01-01 CILLONI D; MESSA F; CARTURAN S; ARRUGA F; DEFILIPPI I; MESSA E; GOTTARDI E; SAGLIO G
Gene expression analysis based on real time PCR of 95 genes coding for tyrosine kinases in Ph negative chronic myeloproliferative disorders
2005-01-01 Arruga F; Gottardi E; Fava M; Carturan S; Messa F;Defilippi I; Morotti A; Messa E; Capella S; Chiarenza A; Giugliano E; Saglio G; Cilloni D
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Letter to the Editor: reply to Martinelli et al. | 2003 | GUERRASIO A; PILATRINO C; D. CILLONI; GOTTARDI E; SAGLIO G | |
| Sodium valproate enhances Imatinib induced apoptosis and growth arrest in Bcr-Abl cell lines | 2003 | Morotti A.; Cilloni D.; Messa F.; Pautasso M.; Rege-Cambrin G.; Pilatrino C.; Guerrasio A.; Gottardi E.; Alberti D; Saglio G | |
| Resveratrol and Valproate induce differentiation of AML blasts through NF-kB inhibition | 2003 | Morotti A; Pautasso M; Cilloni D; Messa F; Baraban D; Gottardi E; Saglio G | |
| Usefulness of quantitative assessment of Wilms tumor suppressor gene expression in chronic myeloid leukemia patients undergoing imatinib therapy. | 2003 | D. CILLONI; SAGLIO G. | |
| MODULATION OF APOPTOSIS | 2004 | Saglio G; Morotti A; Cilloni D | |
| Conventional and novel tools for defining the risk of the individual patient with chronic myeloid leukemia and for monitoring treatment | 2004 | G. SAGLIO; D. CILLONI | |
| Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia | 2004 | SAGLIO G; MOROTTI A; MATTIOLI G; MESSA E; GIUGLIANO E; VOLPE G; REGE-CAMBRIN; G; CILLONI D. | |
| The IKK inhibitor PS1145 allows to overcome Imatinib resistance | 2004 | Cilloni D; Messa F; Arruga F; Defilippi I; Morotti A; Messa E; Carturan S; Fava M; Gottardi E; Martinelli G; Baccarani M; Saglio G | |
| SODIUM VALPROATE ENHANCES IMATINIB INDUCED APOPTOSIS AND GROWTH ARREST IN BCR-ABL CELL LINES | 2004 | Morotti A; Cilloni D; Pautasso M; Baraban D; Messa F; Arruga F; De Filippi I; Messa E; Carturan S; Rege-cambrin G; Pilatrino C; Guerrasio A; Gottardi E; Saglio G | |
| Over-Expression of the P65 Subunit of NF-kB and Increased DNA Binding Activity of NF-kB Is a Common Event Both in Philadelphia Positive and Negative Chronic Myeloproliferative Disorders. | 2004 | Alessandro Morotti; Veronica Ullmannova; Daniela Cilloni; Francesca Messa; Manuela Messa; Ilaria Defilippi; Francesca Arruga; Sonia Carturan; Cedrik Haskovec; Enrico Gottardi; Giuseppe Saglio | |
| Over-expression of the p65 subunit of NF-kB and increased NF-kB binding activity is a common event both in Philadelphia positive and negative Chronic Myeloproliferative Disorders | 2004 | Morotti A; Ullmannova V; Cilloni D; Messa F; Messa E; Defilippi I; Arruga F; Carturan S; Haskovec C; Gottardi E; Saglio G | |
| Glivec and CML: a lucky date | 2004 | SAGLIO G; CILLONI D; RANCATI F; BOANO L. | |
| Molecular response to imatinib in late chronic-phase chronic myeloid leukemia | 2004 | ROSTI G; MARTINELLI G; BASSI S; AMABILE M; TRABACCHI E; GIANNINI B; CILLONI D; IZZO B; DE VIVO A; TESTONI N; CAMBRIN GR; BONIFAZI F; SOVERINI S; LUATTI S; GOTTARDI E; ALBERTI D; PANE F; SALVATORE F; SAGLIO G; BACCARANI M. | |
| Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation | 2004 | CILLONI D; MESSA F; GOTTARDI E; FAVA M; ARRUGA F; DEFILIPPI I; CARTURAN S; MESSA E; MOROTTI A; GIUGLIANO E; REGE-CAMBRIN G; ALBERTI D; BACCARANI M; SAGLIO G | |
| Abl: the prototype of oncogenic fusion proteins | 2004 | G. SAGLIO; D. CILLONI | |
| Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients | 2004 | CILLONI D; CARTURAN S; GOTTARDI E; MESSA F; FAVA M; DEFILIPPI I; ARRUGA F; SAGLIO G. | |
| Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia | 2004 | BACCARANI M; MARTINELLI G; ROSTI G; TRABACCHI E; TESTONI N; BASSI S; AMABILE M; SOVERINI S; CASTAGNETTI F; CILLONI D; IZZO B; DE VIVO A; MESSA E; BONIFAZI F; POERIO A; LUATTI S; GIUGLIANO E; ALBERTI D; FINCATO G; RUSSO D; PANE; F; SAGLIO G; GIMEMA WORKING PARTY ON CHRONIC MYELOID LEUKEMIA. | |
| WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome | 2004 | CILLONI D; SAGLIO G | |
| Myelodysplastic syndromes | 2004 | CILLONI D; MESSA F; CARTURAN S; ARRUGA F; DEFILIPPI I; MESSA E; GOTTARDI E; SAGLIO G | |
| Gene expression analysis based on real time PCR of 95 genes coding for tyrosine kinases in Ph negative chronic myeloproliferative disorders | 2005 | Arruga F; Gottardi E; Fava M; Carturan S; Messa F;Defilippi I; Morotti A; Messa E; Capella S; Chiarenza A; Giugliano E; Saglio G; Cilloni D |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile